Exposure Response Supports Therapeutic Drug Monitoring for Dabigatran Etexilate in Patients with Atrial Fibrillation

Background  Dabigatran etexilate has become widely used for the prevention of stroke in patients with nonvalvular atrial fibrillation (NVAF). Currently, there is limited information in real-world patients relating to dabigatran etexilate exposure and response. Methods  This retrospective cohort stud...

Täydet tiedot

Bibliografiset tiedot
Päätekijät: Simpson, Bryan H., Reith, David M., Medlicott, Natalie J., Smith, Alesha J.
Aineistotyyppi: Online Artikkeli Teksti
Kieli:English
Julkaistu: Georg Thieme Verlag KG 2019
Linkit:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6639112/
https://www.ncbi.nlm.nih.gov/pubmed/31328179
http://dx.doi.org/10.1055/s-0039-1693486

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6639112/
https://www.ncbi.nlm.nih.gov/pubmed/31328179
http://dx.doi.org/10.1055/s-0039-1693486

Samankaltaisia teoksia